HAND proteins: Molecular mediators of cardiac development and congenital heart disease

Trends in Cardiovascular Medicine

Volumn 9, Issue 1-2, 1999, Pages 11-18

  Srivastava, Deepak ^a  

^a Depts Pediat Cardiol Molec B   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELIX LOOP HELIX PROTEIN; MUTANT PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ARCH ANOMALY; BRANCHIAL ARCH; CONGENITAL HEART DISEASE; HEART DEVELOPMENT; HYPOPLASIA; MESODERM; MOUSE; NEURAL CREST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 0033000465     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(98)00033-4     Document Type: Article

References (42)

1. Basson C.T., Cowley G.S., Solomon S.D.et al. The clinical and genetic spectrum of the Holt-Oram syndrome. N Engl J Med. 330:1994;885-891.
2. Basson C.T., Bachinsky D.R., Lin R.C.et al. Mutations in human TBX5 cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet. 15:1997;30-35.
3. Biben C., Harvey R.P. Homeodomain factor Nkx2-5 controls left/right asymmetric expression of bHLH gene eHAND during murine heart development. Genes & Dev. 11:1997;1357-1369.
4. Cross J.C., Flannery M.L., Blanar M.A.et al. Hxt encodes a basic helix-loop-helix transcription factor that regulates trophoblast cell development. Development. 121:1995;2513-2523.
5. Cserjesi P., Brown D., Lyons G.E., Olson E.N. Expression of the novel basic helix-loop-helix gene eHAND in neural crest derivatives and extraembryonic membranes during mouse development. Dev Biol. 170:1995;664-678.
6. Driscoll D.A., Salvin J., Sellinger B.et al. Prevalence of 22q11 microdeletions in Di-George and velocardiofacial syndromes. im-plications for genetic counseling and prenatal diagnosis J Med Genet. 30:1993;813-817.
7. Firulli A.B., McFadden D.G., Lin Q., Srivastava D., Olson E.N. Heart and extra-embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand 1. Nature Genet. 18:1998;260-270.
8. Fishman M.C., Chien K.R. Fashioning the vertebrae heart. earliest embryonic decisions Development. 124:1998;2099-2117.
9. Gentles T.L., Mayer J.E. Jr., Gauvreau K., Newburger J.W. Fontan operation in five hundred consective patients. factors influencing early and late outcome J Thorac Cardiovasc Surg. 114:1997;376-391.
10. Harh J.Y., Paul M.H., Gallen W.J., Friedberg D.Z., Kaplan S. Experimental production of hypoplastic left heart syndrome in the chick embryo. Pediatric Cardiology. 31:1973;51-56.
11. Harvey R.P. NK-2 homeobox genes and heart development. Dev Biol. 178:1996;203-216.
12. Hoffman J.I.E. Incidence of congenital heart disease. I, Postnatal incidence Pediat Cardiol. 16:1995;103-113.
13. Hollenberg S.M., Sternglanz R., Cheng P.F., Weintraub H. Identification of a new family of tissue-specific basic helix-loop helix proteins with a two-hybrid system. Mol Cell Biol. 15:1995;3813-3822.
14. Kelly R., Alonso S., Tajbakhsh S., Cossu G., Buckingham M. Myosin light chain 3F regulatory sequences confer regionalized cardiac and skeletal muscle expression in transgenic mice. J Cell Biol. 129:1995;383-396.
15. Kirby M.L., Waldo K.L. Role of neural crest in congenital heart disease. Circulation. 82:1990;332-340.
16. Kirby M.L., Waldo K.L. Neural crest and cardiovascular patterning. Circ Res. 77:1995;211-215.
17. Kuisk I.R., Li H., Tran D., Capetanaki Y. A single MEF2 site governs desmin transcription in both heart and skeletal muscle during mouse embryogenesis. Dev Biol. 174:1996;1-13.
18. Kuo C.T., Morrisey E., Anandappa R.et al. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev. 11:1997;1048-1060.
19. Kurihara H., Suzuki H., Kodama T.et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature. 368:1994;703-710.
20. Kurihara Y., Kurihara H., Oda H.et al. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J Clin Inv. 96:1995;293-300.
21. Levin M. Left-right asymmetry in vertebrate embryogenesis. Bioessays. 19:1997;287-296.
22. Li L., Miano J.M., Mercer B., Olson E.N. Expression of the SM22 promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol. 132:1996;849-859.
23. Lin Q., Schwartz J.A., Olson E.N. Control of cardiac morphogenesis and myogenesis by the myogenic transcription factor MEF2C. Science. 276:1997;1404-1407.
24. Molkentin J.D., Lin Q., Duncan S.A., Olson E.N. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 11:1997;1061-1072.
25. Olson E.N., Srivastava D. Molecular pathways controlling heart development. Science. 272:1996;671-676.
26. Pizzuti A., Novelli G., Ratti A., Amati F., Mari A., Calabrese G., Nicolis S., Salini V., Mariano B., Scarlato G., Ottolenghi S., Dallapiccola B. UFD1L, a developmentally expressed ubiquitination gene, is deleted in CATCH 22 syndrome. Human Molec Gen. 6:1997;259-265.
27. Riley P., Anson-Cartwright L., Cross J.C. The Hand 1 bHLH transcription factor is essential for placentation and cardiac morphogenesis. Nature Genet. 18:1998;271-275.
28. Ross R.S., Navankasattusas S., Harvey R.P., Chien K.R. An HF-1a/HF-1b/MEF2 combinatorial element confers cardiac ventricular specificity and establishes an anterior-posterior gradient of expression via an Nkx2.5 independent pathway. Development. 122:1996;1799-1809.
29. Schott J., Benson D.W., Basson C.T.et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science. 281:1998;108-111.
30. Sparrow D.B., Kotecha S., Towers N., Mohun T.J. Xenopus eHAND. a marker for the developing cardiovascular system of the embryo that is regulated by bone morphogenetic proteins Mech Dev. 71:1998;151-163.
31. Srivastava D., Cserjesi P., Olson E.N. A subclass of bHLH proteins required for cardiogenesis. Science. 270:1995;1995-1999.
32. Srivastava D., Thomas T., Lin Q., Kirby M.L., Brown D., Olson E.N. Regulation of cardiac mesodermal and neural crest development by the bHLH transcrition factor, dHAND. Nature Genet. 16:1997;154-160.
33. Srivastava D: 1998. Segmental regulation of cardiac development by the basic helix-loop-helix transcription factors, dHAND and eHAND. In Harvey R and Rosenthol N eds. Heart Development 143-155.
34. Srivastava D. Left-right, which way to turn. Nature Genet. 17:1997;252-254.
35. Thomas T., Yamagishi H., Overbeek P.A., Olson E.N., Srivastava D. The bHLH factors, dHAND and eHAND, specify pulmonary and systemic cardiac ventricles independent of left-right sidedness. Dev Biol. 196:1998;228-236. a.
36. Thomas T., Kurihara H., Yamagishi H.et al. A signaling cascade involving endothelin-1, dHAND and Msx1 regulates development of neural crest-derived branchial arch mesenchyme. Development. 125:1998;3005-3014. b.
37. Van Mierop L.H., Kutsche L.M. Cardiovascular anomalies in DiGeorge syndrome and importance of neural crest as a possible pathogenic factor. Am J Cardiol. 58:1986;133-137.
38. Waldo K.L., Kumiski D., Kirby M.L. Cardiac neural crest is essential for the persistence rather than the formation of an arch artery. Dev Dyn. 205:1996;281-292.
39. Waldo K., Miyagawa-Tomita S., Kumiski D., Kirby M.L. Cardiac neural crest cells provide new insight into septation of the cardiac outflow tract. aortic sac to ventricular septal closure Dev Biol. 196:1998;129-144.
40. Wilson D.I., Burn J., Scambler P., Goodship J. DiGeorge syndrome. part of CATCH-22 J Med Genet. 30:1993;852-856.
41. Yamagishi H., Garg V., Matsuoka R., Thomas T., Srivastava D. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. Science. in press:1999.
42. Yutzey K., Bader D. Diversification of cardiomyogenic cell lineages during early heart development. Circ Res. 77:1995;216-219.